DK0409999T3 - Anvendelse af L-ascorbin-2-phosphat-syre eller et farmaceutisk acceptabelt salt deraf til fremstilling af en skylleopløsning til hindring af skader op intraokulart væv - Google Patents

Anvendelse af L-ascorbin-2-phosphat-syre eller et farmaceutisk acceptabelt salt deraf til fremstilling af en skylleopløsning til hindring af skader op intraokulart væv

Info

Publication number
DK0409999T3
DK0409999T3 DK90902367.3T DK90902367T DK0409999T3 DK 0409999 T3 DK0409999 T3 DK 0409999T3 DK 90902367 T DK90902367 T DK 90902367T DK 0409999 T3 DK0409999 T3 DK 0409999T3
Authority
DK
Denmark
Prior art keywords
ascorbine
prepare
pharmaceutically acceptable
acceptable salt
tissue damage
Prior art date
Application number
DK90902367.3T
Other languages
Danish (da)
English (en)
Inventor
Takashi Awata
Shunji Sogo
Takahiro Matsumoto
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of DK0409999T3 publication Critical patent/DK0409999T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04Phosphates; Phosphites; Polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/665Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK90902367.3T 1989-02-02 1990-01-26 Anvendelse af L-ascorbin-2-phosphat-syre eller et farmaceutisk acceptabelt salt deraf til fremstilling af en skylleopløsning til hindring af skader op intraokulart væv DK0409999T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2547789 1989-02-02

Publications (1)

Publication Number Publication Date
DK0409999T3 true DK0409999T3 (da) 1993-11-01

Family

ID=12167127

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90902367.3T DK0409999T3 (da) 1989-02-02 1990-01-26 Anvendelse af L-ascorbin-2-phosphat-syre eller et farmaceutisk acceptabelt salt deraf til fremstilling af en skylleopløsning til hindring af skader op intraokulart væv

Country Status (7)

Country Link
EP (1) EP0409999B1 (de)
AT (1) ATE94394T1 (de)
CA (1) CA2026316A1 (de)
DE (1) DE69003323T2 (de)
DK (1) DK0409999T3 (de)
ES (1) ES2058891T3 (de)
WO (1) WO1990008548A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2115606A1 (en) * 1993-02-22 1994-08-23 Takahiro Matsumoto Intraocular irrigating and enucleated eyeball preservative composition
CA2129509A1 (en) * 1993-09-10 1995-03-11 Kazumi Ogata Pharmaceutical composition for renal disorder and a dialysis solution for extracorporeal hemodialysis
CA2205863A1 (en) * 1994-12-19 1996-06-27 Taisho Pharmaceutical Co., Ltd. Liposome eye drops

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3812251A (en) * 1966-12-10 1974-05-21 Takeda Chemical Industries Ltd Stabilized aqueous composition
GB1431841A (en) * 1973-01-15 1976-04-14 Evans S C Ophthalmic-nutritional preparations
JPS61246117A (ja) * 1985-04-22 1986-11-01 Masako Motomura 抗アレルギ−点眼薬
US4704352A (en) * 1985-06-25 1987-11-03 Baxter Travenol Laboratories, Inc. L-ascorbate-2-phosphate salts in blood cell storage
US4696917A (en) * 1985-08-01 1987-09-29 Lindstrom Richard L Irrigation solution
US4620979A (en) * 1985-08-02 1986-11-04 Schachar Ronald A Ophthalmological irrigating solution containing ascorbate
JPS62223117A (ja) * 1986-03-25 1987-10-01 Zeria Kagaku Kk 角膜疾患用点眼液
JPH06263523A (ja) * 1993-03-05 1994-09-20 Harima Ceramic Co Ltd 炭素含有不焼成煉瓦の製造方法

Also Published As

Publication number Publication date
CA2026316A1 (en) 1990-08-03
DE69003323D1 (de) 1993-10-21
DE69003323T2 (de) 1994-02-17
EP0409999A1 (de) 1991-01-30
ATE94394T1 (de) 1993-10-15
ES2058891T3 (es) 1994-11-01
WO1990008548A1 (fr) 1990-08-09
EP0409999B1 (de) 1993-09-15
EP0409999A4 (en) 1991-08-21

Similar Documents

Publication Publication Date Title
ES2031876T3 (es) Un procedimiento para la preparacion de 5,6-dihidro-2-(fenil sustituido)-1,2,4,-triazin-3,5(2h,4h)-dionas.
DK8885A (da) N-heterocyclyl-4-piperidinaminderivater og fremgangsmaade til fremstilling deraf
DK339184D0 (da) Imidazoliumforbindelser, mellemprodukter hertil og fremgangsmaade til deres anvendelse
NO872880D0 (no) Fremgangsmaate for fremstilling av difenylpropylamin-derivater.
DK65987D0 (da) 1,4-benzoxazinderivater eller syreadditionssalte deraf, fremgangsmaade til fremstilling af forbindelserne og forbindelsernes anvendelse
ES2147629T3 (es) Guanidinas de acido alquenilcarboxilico sustituidas con un grupo fluorofenilo como inhibidores del intercambio de na+/nh+, su procedimiento de preparacion y su uso como medicamento o agente diagnostico asi como el medicamento que las contiene.
DK118578A (da) Fr&mgangsmaade til fremstilling af pyridinylaminoalkylethere,n-oxider eller physiologisk acceptable syreadditionssalte deraf
DK397383A (da) 2-nitro-1,1-ethendiaminer, fremgangsmaader til fremstilling deraf samt deres anvendelse som laegemidler
JPS567716A (en) Preventive and remedy for cerebral angiospasm
DK178883D0 (da) 2-(2'-hydroxy-3'-(1,1-dimethylpropylamino)-propoxy)-beta-phenylpropiophenon, syreadditionssalte deraf, fremgangsmade til fremstilling deraf samt farmaceutiske praeparater med indhold deraf
DK0409999T3 (da) Anvendelse af L-ascorbin-2-phosphat-syre eller et farmaceutisk acceptabelt salt deraf til fremstilling af en skylleopløsning til hindring af skader op intraokulart væv
DK540283A (da) Fremgangsmaade til fremstilling af thienyleddikesyreamider eller fysiologisk taalelige syreadditionssalte deraf
DK429480A (da) Phosphonohydroxyeddikesyre fremgangsmaader til fremstilling deraf samt anvendelse deraf som laegemiddel
ES2122962T3 (es) Derivados de alquileno-dioxibenceno opticamente activos y su uso en terapia.
NO158096C (no) Fremgangsmaate for fremstilling av terapeutisk aktivt (z)-1,2-difenyl-l-(4-(2-(n,n-dimetylamino)etoksylfenyl)-l-buten (i) eller tamoxifen og syreaddisjonssalter derav.
DK157021C (da) Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf
DK154431C (da) Analogifremgangsmaade til fremstilling af 10-halogen-e-homoeburnanderivater eller epimere, optisk aktive antipoder eller fysiologisk acceptable syreadditionssalte deraf
DK398283D0 (da) Fremgangsmade til fremstilling af 1,4-dihydropyridinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK316682A (da) Fremgangsmaade til fremstilling af optisk aktive dipeptider
DK0417875T3 (da) 1-methoxypyrimidinyl-1H-1,2,4-triazol-3-sulfonsyrenitroanilider, fremgangsmåde til fremstilling heraf og deres anvendelse som middel med herbicid virkning
DK314587A (da) 1,4-dihydropyridinderivater, fremgangsmaade til deres fremstilling og laegemidler, der indeholder disse forbindelser
SU1503781A2 (ru) Фиксатор дл чрескостного остеосинтеза
DE68928788T2 (de) Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten
DK333081A (da) Fremgangsmaade til fremstilling af 2-(4-hydroxyalkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-onderivater eller terapeutisk aacceptable syreadditionssalte deraf
DK152123C (da) Analogifremgangsmaade til fremstilling af 3,4,5-trihydroxypiperidinderivater eller farmaceutisk acceptable salte eller stereoisomere deraf